Abstract:Objectives Evidence from clinical trials and animal experiments has shown that oestrogen has anti-atherosclerotic effects that are independent of its cholesterol-lowering activity; these activities include reducing the proliferation of smooth muscle cells and leukocyte adhesion and increasing the synthesis of nitric oxide. However, whether oestrogen can regulate foam cell formation remains unknown. Here, we investigated the effects of 17β-oestradiol (E2) on cholesterol efflux in vivo and in vitro. Methods ApoE-null mice (B6.129P2-ApoEtm1Unc) underwent an ovariectomy (OVX) or Sham operation at 5 weeks of age and then were treated with E2 or vehicle for the following 8 weeks. After above treatment, serum and aorta of mice were harvested and then lipid level, plaque size and composition were detected. RAW267.4 cells were pretreated with or without interferon-gamma (IFN-gamma) for 12 h then treated with E2 for additional 12 h, then ATP-binding cassette transporter A1 (ABCA1), ATP-binding cassette transporter G1 (ABCG1) and CD36 expression and cholesterol efflux rate to apoA I and HDL were detected. Results Compared with the vehicle-treated mice, the serum total cholesterol level were decreased by 27.72% in the Sham group and 35.32% in the OVX+E2 group p<0.01 for both), and the serum triglyceride level was decreased by 22.64% in the Sham group and 23.84% in the OVX+E2 group p<0.05 and p < 0.01, respectively). Compared with the OVX group, the size of the plaque area was significantly reduced by 22.03% in the Sham group and by 21.84% in the OVX+E2 group p<0.01 for both). Oil Red O staining showed that the lipid deposits in the plaques decreased by 20.57% and 30.36%, respectively p<0.01 for both). The immunohistochemical staining showed the percentage of ABCA1-positive areas in the plaque were 1.61 and 1.57 times higher p<0.01 for both) in the Sham and OVX+E2 groups, respectively, than in the OVX group. According to above results, compared with the OVX group, the mRNA expression of ABCA1 in the aorta also increased by 2.09 and 2.43 times, respectively p<0.01 for both). In vitro, E2 treatment alone did not influence ABCA1 expression, but reversed the IFN-gamma inhibited ABCA1 expression of RAW 264.7 cells. Compared with the untreated cells, ABCA1 mRNA levels decreased by 35.29% in the presence of IFN-gamma and were reversed to 87.25% p<0.01, for both) by the E2 treatment, no change was found in ABCG1 or CD36 expression. Finally, we also found that E2 enhanced the cholesterol efflux to apoA I (28.66±1.76% for E2 vs 15.80±3.77% for control, p<0.01) in RAW264.7 cells, but not to HDL. Conclusions In summary, E2 increased ABCA1 expression and cholesterol efflux, both in vivo and in vitro. Thus, E2 delayed the atherosclerotic plaque progression in ApoE-null mice. These results provide new insight into the athero-protective effects of oestrogen.

Effect of ethinyl estradiol treatment on lipoproteins and LCAT activity in aged rats

Antioxidant Effects of 2,3-Dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran and Alpha-Tocopherol in Hyperlipidemic Mice As Evaluated by Hydroxyoctadecadienoic Acid and 7-Hydroxycholesterol

Estrogen modulates phospholipid acylation in red blood cells: relationship to cell aging

Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation.

Age and sex mediated changes in epicardial fat adipokines

Effect of Estrogen Replacement Therapy in the Early Phase on Atherosclerosis in Rats

Effects of Estradiol on Liver Estrogen Receptor-Alpha and Its Mrna Expression in Hepatic Fibrosis in Rats

The Effects of Estradiol Valerate and Remifemin on Liver Lipid Metabolism.

Estrous Cycles, Decidual Cell Response and Uterine Estrogen and Progesterone Receptor in Fischer 344 Virgin Aging Rats

Differences in Cholesterol Metabolism, Hepato-Intestinal Aging, and Hepatic Endocrine Milieu in Rats as Affected by the Sex and Age

A linoleic acid enriched diet increases serum cholesterol esterification by lecithin:cholesterol acyltransferase in meal-fed rats

Inhibition of cholesterylester accumulation by 17 beta-estradiol in macrophages through activation of neutral cholesterol esterase

Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet

Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans

GW24-e2301 17β-estradiol reduces lipid accumulation in vascular smooth muscle cells through liver X receptor α pathway

β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia

17Β-Estrodial INCREASES ABCA1 EXPRESSION AND CHOLESTEROL EFFLUX TO APOA I IN VIVO AND IN VITRO

Effects of Estradiol Valerate on Splenocyte Apoptosis and Ovarian Function of Climacteric Rats

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling

Ethanol Extract of Propolis Attenuates Liver Lipid Metabolism Disorder in High-Fat Diet-Fed SAMP8 Mice

A combined transcriptomics and proteomics approach to reveal the mechanism of AEE relieving hyperlipidemia in ApoE-/- mice